Smart strategies to early drug development


Drug Development Smart Strategies:

  1. Partnerability:

Partnering is a core element for most Biotech business models. Partnering at the optimal point of their asset. Optimal Point is defined by proactively updating when new information arrives:

  • Scientific read-out
  • Competitive Landscape
  • Recent deals
  • Regulatory decisions
  • etc...


How much of a lawyer should a Contract Manager be (if at all)?

study contracts training at ECCRT

CTA negotiations can be a hurdle for trial initiation

Our top 10 Q&A on Trial Master File

Trial Master File Q&A

1. What is a Trial Master File (TMF)?

Each clinical trial comes with documentation of trial related activities, legal requirements and trial data. All trial related documents need to be collected, organised, managed and maintained in what is called the “Trial Master File” or Electronic Trial Master File (eTMF).

3 Facts about Risk Based Monitoring you need to understand

Risk Based Monitoring training at ECCRT

Risk Based Monitoring is a new approach of study monitoring. This has been first emphasized as a better method to reduce quality issues by FDA in August 2013 and then EMA in November 2013. This approach is now also a requirement from ICH-GCP since November 2016 when the ICH-GCP E6 (R2) has been published.

5 facts you need to know about a CRO

Many biotech companies underestimate the importance of selecting the right CRO: they do not realise that they put their (very often) single asset into the hand of an external party. As a fact, multiple biotech organisations didn't make it simply because they selected the wrong partner for their venture. Here are a few facts we want to share to help you succeed in your collaboration with a CRO.

1. Sites like working with CROs